Advertisement

Testicular Tumors

  • Jonathan H. RossEmail author
Living reference work entry
  • 9 Downloads

Abstract

Prepubertal testis tumors are distinct from their adolescent and adult counterparts in histological characteristics, molecular biology, and clinical behavior. In the absence of an age-adjusted elevation in alpha-fetoprotein (AFP), the initial surgical approach for pediatric testis tumors should be an inguinal exploration with excisional biopsy and frozen section analysis. Most of these patients will have a benign tumor and require no further evaluation or treatment. Those patients that harbor the most common malignancy – yolk sac tumor – usually have stage I disease that can be managed with observation. Patients with metastatic disease and those stage I patients who progress on observation can almost always be cured with platinum based multiagent chemotherapy. Indeed, the outlook for prepubertal patients with testicular tumors is even better than that for adults and the emphasis in recent years has been on reducing the morbidity of both the surgical and adjuvant therapies for these children. For adolescents with malignant germ cell tumors, management usually follows that recommended for adults with an inguinal orchiectomy as the initial approach unless there is a high suspicion of a benign tumor. Postsurgical management for stage I tumors generally involves surveillance with consideration of a staging retroperitoneal lymph node dissection (RPLND) in high risk patients and those with marker-negative stage IIA disease. Most patients with metastatic disease receive platinum-based chemotherapy. Any residual mass following chemotherapy in the setting of normal tumor markers should be excised and a bilateral nerve-sparing RPLND should be considered.

Keywords

Neoplasms Germ cell Testicular neoplasm Pediatric Adolescent 

References

  1. Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002;38:1–10.CrossRefGoogle Scholar
  2. Cushing B, Giller R, Cullen J, et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9049 and Children’s Cancer Group 8882. J Clin Oncol. 2004;22:2691–700.CrossRefGoogle Scholar
  3. De Backer A, Madern G, Pieters R, et al. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors. Eur J Pediatr Surg. 2008;18:1–6.CrossRefGoogle Scholar
  4. Dudani R, Giordano L, Sultania P, et al. Juvenile granulosa cell tumor of testis: case report and review of literature. Am J Perinatol. 2008;25:229–31.CrossRefGoogle Scholar
  5. Gobel U, Calaminus G, Engert J, et al. Teratomas of infancy and childhood. Med Pediatr Oncol. 1998;31:8–15.CrossRefGoogle Scholar
  6. Guler E, TezerKutluk M, Buyukpamukcu N, et al. Testicular germ cell tumors in childhood: treatment results of 52 patients. Pediatr Hematol Oncol. 2004;21:49–56.CrossRefGoogle Scholar
  7. Haas R, Schmidt P, Gobel U, Harms D. Testicular germ cell tumors an update – results of the German cooperative studies 1982–1997. Klin Padiatr. 1999;211:300–4.CrossRefGoogle Scholar
  8. Kusler KA, Poynter JN. International testicular cancer incidence rates in children, adolescents and young adults. Cancer Epidemiol. 2018;56:106–11.CrossRefGoogle Scholar
  9. Lo Curto M, Lumia F, Alaggio R, et al. Malignant germ cell tumors in childhood: results of the first Italian cooperative study “TCG 91”. Med Pediatr Oncol. 2003;41:417–25.CrossRefGoogle Scholar
  10. Maizlin II, Dellinger M, Gow KW, et al. Testicular tumors in prepubescent patients. J Pediatr Surg. 2018;53(9):1748–52.CrossRefGoogle Scholar
  11. Mann J, Raafat F, Robinson K, et al. The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol. 2000;18:3809–18.CrossRefGoogle Scholar
  12. Palmer R, Foster N, Vowler S, et al. Malignant germ cell tumours of childhood: new associations of genomic imbalance. Br J Cancer. 2007;96:667–76.CrossRefGoogle Scholar
  13. Pohl H, Shukla A, Metcalf P, et al. Prepubertal testis tumors: actual prevalence rate of histological types. J Urol. 2004;172:2370–2.CrossRefGoogle Scholar
  14. Radford A, Peycelon M, Haid B, Powis M, Lakshminarayanan B. Testicular-sparing surgery in the pediatric population: multicenter review of practice with review of the literature. Curr Opin Urol. 2019;29(5):481–486.  https://doi.org/10.1097/MOU.0000000000000652CrossRefGoogle Scholar
  15. Rogers P, Olson T, Cullen J, et al. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9048 and Children’s Cancer Group 8891. J Clin Oncol. 2004;22:3563–9.CrossRefGoogle Scholar
  16. Ross J, Billmire D, Rescorla F, et al. Management of the retroperitoneum in children and adolescents with malignant germ cell tumors of the testis: a report from the Children’s Oncology Group. Abstract at the American Academy of Pediatrics Annual Meeting, New Orleans, 2012.Google Scholar
  17. Schlatter M, Rescorla F, Giller R, et al. Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children’s Cancer Group/Pediatric Oncology Group. J Pediatr Surg. 2003;38:319–24.CrossRefGoogle Scholar
  18. Terenziani M, Piva L, Spreafico F, et al. Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases. J Pediatr Hematol Oncol. 2002;24:454–8.CrossRefGoogle Scholar
  19. Thomas J, Ross J, Kay R. Stromal testis tumors in children: a report from the prepubertal testis tumor registry. J Urol. 2001;166:2338–40.CrossRefGoogle Scholar
  20. Valla J. Testis-sparing surgery for benign testicular tumors in children. J Urol. 2001;165:2280–3.CrossRefGoogle Scholar
  21. Washecka R, Dresner M, Honda S. Testicular tumors in Carney’s complex. J Urol. 2002;167:1299–302.CrossRefGoogle Scholar
  22. Woo LL, Ross JH. The role of testis-sparing surgery in children and adolescents with testicular tumors. Urol Oncol. 2016;34(2):76–83.CrossRefGoogle Scholar
  23. Wood LW, Kollmannsberger C, Jewett M, et al. Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J. 2010;4:E19–38.CrossRefGoogle Scholar
  24. Wu D, Shen N, Lin X, et al. Prepubertal testicular tumors in China: a 10-year experience with 67 cases. Pediatr Surg Int. 2018;34(12):1339–43.CrossRefGoogle Scholar
  25. Ye Y, Sun X, Zheng F, et al. Clinical analysis of management of pediatric testicular germ cell tumors. Urology. 2012;79:892–8.CrossRefGoogle Scholar
  26. Zu’bi F, Koyle MA, Rickard M, et al. Testis-sparing surgery for pediatric Leydig cell tumors: evidence of favorable outcomes irrespective of surgical margins. Urology. 2019. pii: S0090-4295(19)30829-5.;  https://doi.org/10.1016/j.urology.2019.09.016.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Rush UniversityChicagoUSA

Personalised recommendations